with gout, except for a single recommendation regarding the use of ULT in individuals with asymptomatic hyperuricemia, which is defined as an SU concentration of â‰¥6.8 mg/dl with no prior gout flares or subcutaneous tophi. Patients with evidence of monosodium urate monohydrate (MSU) deposition on advanced imaging may still be considered asymptomatic if they have not had a prior gout flare or subcutaneous tophi. These guidelines do not directly address the impact of gout or hyperuricemia on other